216 related articles for article (PubMed ID: 32122868)
21. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
22. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
23. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
[TBL] [Abstract][Full Text] [Related]
24. 3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors.
Jitonnom J; Meelua W; Tue-Nguen P; Saparpakorn P; Hannongbua S; Chotpatiwetchkul W
Chem Biol Interact; 2024 Jun; 396():111040. PubMed ID: 38735453
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential hit compounds for Dengue virus NS2B/NS3 protease inhibitors by combining virtual screening and binding free energy calculations.
Wichapong K; Nueangaudom A; Pianwanit S; Sippl W; Kokpol S
Trop Biomed; 2013 Sep; 30(3):388-408. PubMed ID: 24189670
[TBL] [Abstract][Full Text] [Related]
26. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
27. Papaya Leaf Extracts as Potential Dengue Treatment: An In-Silico Study.
Madushanka A; Verma N; Freindorf M; Kraka E
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293162
[TBL] [Abstract][Full Text] [Related]
28. Novel dengue virus NS2B/NS3 protease inhibitors.
Wu H; Bock S; Snitko M; Berger T; Weidner T; Holloway S; Kanitz M; Diederich WE; Steuber H; Walter C; Hofmann D; Weißbrich B; Spannaus R; Acosta EG; Bartenschlager R; Engels B; Schirmeister T; Bodem J
Antimicrob Agents Chemother; 2015 Feb; 59(2):1100-9. PubMed ID: 25487800
[TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4.
Nguyen TT; Lee S; Wang HK; Chen HY; Wu YT; Lin SC; Kim DW; Kim D
Molecules; 2013 Dec; 18(12):15600-12. PubMed ID: 24352016
[TBL] [Abstract][Full Text] [Related]
30. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
31. A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.
Costa RAD; Rocha JAPD; Pinheiro AS; Costa ADSSD; Rocha ECMD; Silva RC; Gonçalves ADS; Santos CBR; Brasil DDSB
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807364
[TBL] [Abstract][Full Text] [Related]
32. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
Majerová T; Novotný P; Krýsová E; Konvalinka J
Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
[TBL] [Abstract][Full Text] [Related]
33. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.
Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Panwar A; Lucas SJ; Pandey A; Kang SG
Sci Rep; 2019 Dec; 9(1):19059. PubMed ID: 31836806
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS
Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793
[TBL] [Abstract][Full Text] [Related]
35. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC
Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380
[TBL] [Abstract][Full Text] [Related]
36. Inhibitor Bound Dengue NS2B-NS3pro Reveals Multiple Dynamic Binding Modes.
Gibbs AC; Steele R; Liu G; Tounge BA; Montelione GT
Biochemistry; 2018 Mar; 57(10):1591-1602. PubMed ID: 29447443
[TBL] [Abstract][Full Text] [Related]
37. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
38. An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever.
Powers CN; Setzer WN
Comb Chem High Throughput Screen; 2016; 19(7):516-36. PubMed ID: 27151482
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
[TBL] [Abstract][Full Text] [Related]
40. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]